Business news
The latest business news from across the chemistry-using industries, including mergers and acquisitions, legal and patent disputes, regulation and commercial performance, from the Royal Society of Chemistry's magazine, Chemistry World
-
BusinessAt least 51 deaths in Argentina linked to tainted medical fentanyl
Investigation reveals history of regulatory failures as pharmaceutical company faces criminal charges over Argentina’s deadliest drug contamination scandal
-
BusinessFour dead after nitrogen leak at pharma factory in India
Incident at Medley Pharmaceuticals’ Boisar–Tarapur plant leaves two others in a serious condition
-
BusinessIndia introduces new rules to tackle chemical contamination sites
New legislation provides a legal framework for assessment and cleanup of 189 named chemicals
-
BusinessWill oral weight loss drugs challenge injectables?
Pills may offer convenience for manufacturers, but it’s not clear they will overtake existing drugs
-
BusinessThe challenge of developing oral alternatives to peptide weight loss drugs
Companies are racing to develop alternatives to injectable diabetes and weight loss drugs
-
OpinionCheap virgin plastic limits recycling potential
Global plastic treaty negotiations risk being derailed by minority opposed to production caps
-
BusinessChemours ordered to immediately limit PFAS emissions into Ohio River
US judge grants injunction to reduce Gen-X discharges from West Virginia plant to permitted levels
-
Opinion‘Creative destruction’ in the chemistry lab
Some obsolete lab equipment is quickly replaced, while other items are stubbornly persistent. What modern tech will survive to the 2060s?
-
BusinessMerck & Co to cut 6000 jobs, Moderna to cut around 500
Both firms aiming to make significant reductions in annual costs by reorganising
-
BusinessDuPont and spin-offs settle with New Jersey over PFAS contamination
Proposed deal with the US state includes $875 million in damages, plus clean-up funds
-
OpinionIntergovernmental panel on chemicals, waste and pollution needs diverse input
Balancing industrial expertise against unwanted commercial influence is not easy but shouldn’t be discounted
-
BusinessSarepta gene therapy deaths highlight tragic rare disease dilemma
Regulators block Duchenne muscular dystrophy treatment after fatal side-effects outweigh questionable efficacy
-
OpinionLosing sleep over pesticide exposure
Managing exposure risks poses questions about the extent of producers’ and regulators’ responsibilities for safety
-
OpinionChina’s drug development charge
Reforms and state support have fuelled domestic and foreign investment in pharmaceutical
-
-
BusinessTwo more European crackers to close
Sabic will not reopen UK plant and Dow will close another in Germany
-
BusinessWill HIV prevention get where it’s needed?
Gilead and its partners’ efforts to distribute generic lenacapavir could be derailed by cuts in international aid budgets
-
OpinionGetting good at human tasks
’What do you mean you had to lock the NMR with an oscilloscope and shim the magnet by hand?’
-
BusinessFatal explosion and fire at Indian pharmaceutical ingredients plant
At least 42 dead and 25 injured at Sigachi Industries near Hyderabad
-
Business11 executives jailed over Italian PFAS pollution
Convictions relate to groundwater contamination around Miteni fluorochemicals plant